Much valuable research carried out in UK universities is funded by charitable organisations. Through our partnership with Regener8 we have been able to provide support to charities at a national level. We work directly with researchers to raise translational awareness among project leaders and support the commercialisation process by offering expert advice in product development and de-risking during proof of concept projects.
In 2014 we set up a new partnership with Arthritis Research UK to offer proof of concept awards for research that will improve the lives of people suffering from arthritis. The programme, funded by Arthritis RUK, invites researchers to apply for awards of up to £100,000 for one-year projects to progress research ideas with commercial potential.
Arthritis RUK is the biggest funder of research into the cause, treatment and cure of all forms of arthritis and musculoskeletal disorders in the UK and it has a long-term commitment to preventing the onset of arthritis, developing a cure for the disease and transforming the lives of sufferers.
We invited proposals for research projects that address a range of musculoskeletal conditions; in particular projects that are developing medical devices, orthotics, implantable therapeutic delivery, assisted living technologies and imaging. The support we offer to successful project leaders includes expertise in product development, speeding up the route to market and reducing the risk of late stage failure.
The Medical Technologies IKC’s partnership with Orthopaedic Research UK enables us to contribute to proof of concept projects arising from the charity’s most commercially promising scientific breakthroughs.
These projects could provide important solutions that will help improve the lives of patients affected by musculoskeletal disorders. Our support provides both funding and specialist innovation expertise to encourage investment into these projects.
The first project supported through this partnership is being developed at the University of East Anglia and Norfolk and Norwich Hospital. It is looking at developing a diagnostic predictor test for patients suffering from Dupuytren’s disease. This disease is an inherited condition which affects the connective tissues in the hand, causing fingers to bend inward. Researchers at these institutions are developing a biomarker screening test that will allow clinicians to predict the likely progression of the disease and select the optimal treatment.